Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference97 articles.
1. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired;Ahmadzadeh;Blood,2009
2. Vaccines combined with immune checkpoint antibodies promote cytotoxic T-cell activity and tumor eradication;Ali;Cancer Immunol. Res.,2016
3. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma;Andtbacka;J. Clin. Oncol.,2015
4. Patterns of clinical response with talimogene laherparepvec (T-VEC) in patients with melanoma treated in the OPTiM phase III clinical trial;Andtbacka;Ann. Surg. Oncol.,2016
5. Phase Ib study of MEDI4736, a programmed cell death ligand-1 (PD-L1) antibody, in combination with tremelimumab, a cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) antibody, in patients (pts) with advanced NSCLC;Antonia;J. Clin. Oncol.,2015
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11
2. Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells;npj Precision Oncology;2024-07-29
3. Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high‐risk pediatric cancer patients;International Journal of Cancer;2024-07-03
4. Unlocking cancer vaccine potential: What are the key factors?;Human Vaccines & Immunotherapeutics;2024-04-02
5. Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models;Journal for ImmunoTherapy of Cancer;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3